1-20 of 63
Guido Kroemer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3813: Multipronged approach identifying new hallmarks of antibiotics-mediated immunosuppression in a prospective trial of cancer immunotherapy

Free
Carolina Alves Costa Silva, Giacomo Vitali, Yasmine Hassani, Estelle Menu, Adele Bonato, Deborah Suissa, Lorenzo Belluomini, Anna Reni, Valerio Iebba, Roxanne Birebent, Sylvère Durand, Guillermo Hernandez, Marie Xiberras, Caroline Flament, Anne-Laure Mallard de La Varende, Simon Thomas, Milieu Intérieur Consortium, ONCOBIOTICS network, Stéphane Ranque, Pierre Edouard Fournier, Joel Doré, Guido Kroemer, Damien Drubay, Laurence Zitvogel, Lisa Derosa
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3813.
https://doi.org/10.1158/1538-7445.AM2025-3813
Published: 21 April 2025
View articletitled, Abstract 3813: Multipronged approach identifying new hallmarks of antibiotics-mediated immunosuppression in a prospective trial of cancer immunotherapy
Journal Articles

Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)

Free
Jade Maillou, Reilly Pidgeon, Diogjena Katerina Prifti, Meriem Messaoudene, Sreya Duttagupta, Myriam Benlaifaoui, Yongjia Hu, Alysé Filin, Mayra Ponce, Wiam Belkaid, Julie Malo, Guido Kroemer, Sylvère Durand, Olivier Barbier, Nathalie Daaboul, Normand Blais, Mustapha Thefe, Marie Florescu, Rahima Jamal, Wilson Miller, Antoine Desilets, Bastien Castagner, Arielle Elkrief, Bertrand Routy
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 2223.
https://doi.org/10.1158/1538-7445.AM2025-2223
Published: 21 April 2025
View articletitled, Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)
Journal Articles

Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)

Free
Sreya Duttagupta, Meriem Messaoudene, Rahima Jamal, Catalin Mihalcioiu, Nicolas Marcoux, Sebastian Hunter, Gianmarco Piccinno, Michal Puncochár, Karl Bélanger, Mustapha Tehfe, Normand Blais, Scott Owen, Jacques Raphael, Jade Maillou, Yongjia Hu, Myriam Benlaifaoui, Somayeh Nilli, John Lenehan, Wiam Belkaid, Seema Nair Parvathy, Diogjena Katerina Prifti, Marine Fidelle, Seunghee Kim-schulze, Thomas Marron, Sylvere Durand, Guido Kroemer, Nicola Segata, Lisa Derosa, Laurence Zitvogel, Antoine Desilets, Michael Silverman, Saman MalekiVareki, Bertrand Routy, Arielle Elkrief
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 2210.
https://doi.org/10.1158/1538-7445.AM2025-2210
Published: 21 April 2025
View articletitled, Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)
Journal Articles

Abstract 6423: Multiomic functional biomarkers for predicting the transition from inflammation to cancer

Free
Marine Fidelle, Deborah Suissa, Aline Renneville, Tarek Ben-Ahmed, Sylvere Durand, Olivier Caron, Olaf Mercier, Lisa Derosa, Birgit Geoerger, Guido Kroemer, Damien Drubay, Suzette Delaloge, Tatiana Kuznetsova, David Boulate, Laurence Zitvogel
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6423.
https://doi.org/10.1158/1538-7445.AM2025-6423
Published: 21 April 2025
View articletitled, Abstract 6423: Multiomic functional biomarkers for predicting the transition from inflammation to cancer
Journal Articles

Abstract 5927: ACBP/DBI inhibition suppresses NASH-induced hepatocarcinogenesis

Free
Sijing Li, Omar Motiño, Flavia Lambertucci, Maria Chiara Maiuri, Isabelle Martins, Guido Kroemer
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5927.
https://doi.org/10.1158/1538-7445.AM2024-5927
Published: 22 March 2024
View articletitled, Abstract 5927: ACBP/DBI inhibition suppresses NASH-induced hepatocarcinogenesis
Journal Articles

Abstract F3-2: Fasting and caloric restriction mimetics stimulate anticancer immunosurveillance

Free
Guido Kroemer
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): F3-2.
https://doi.org/10.1158/1538-7445.SABCS22-F3-2
Published: 01 March 2023
View articletitled, Abstract F3-2: Fasting and caloric restriction mimetics stimulate anticancer immunosurveillance
Journal Articles

Abstract 1353: Immunomodulatory effects of valproic acid in combination with cisplatin and cetuximab in head and neck squamous cell carcinoma

Free
Federica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca, Laura Grumetti, tania Moccia, carlo vitagliano, susan costantini, francesca capone, francesca collina, Lucia Gabriele, stefania parlato, Giulia Romagnoli, Oliver Kepp, Guido Kroemer, Elena Di Gennaro, Alfredo Budillon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1353.
https://doi.org/10.1158/1538-7445.AM2022-1353
Published: 15 June 2022
View articletitled, Abstract 1353: Immunomodulatory effects of valproic acid in combination with cisplatin and cetuximab in head and neck squamous cell carcinoma
Journal Articles

HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy

Available to Purchase
Ke Liu, Jun Huang, Jiao Liu, Changfeng Li, Guido Kroemer, Daolin Tang, Rui Kang
Journal: Cancer Research
Cancer Res (2022) 82 (10): 2003–2018.
https://doi.org/10.1158/0008-5472.CAN-21-3917
Published: 16 May 2022
View articletitled, HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy
Open the PDF for HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Free
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer, Virginie Nourtier, Xavier Préville, Eric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (15): 4146–4157.
https://doi.org/10.1158/0008-5472.CAN-16-2165
Published: 01 August 2017
View articletitled, Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
Open the PDF for Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract 4309: Mode of action of LTX315-induced cell death

Free
HENG ZHOU, Allan Sauvat, Sylvère Durand, Sabrina Forveille, Takahiro Yamazaki, Sylvie Souquere, Valentina Sica, Øystein Rekdal, Oliver Kepp, Guido Kroemer
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4309.
https://doi.org/10.1158/1538-7445.AM2017-4309
Published: 01 July 2017
View articletitled, Abstract 4309: Mode of action of LTX315-induced cell death
Journal Articles

Abstract 4563: Local and abscopal effects in oncolytic virotherapy are boosted by immune checkpoint blockade, immunogenic chemotherapy, or IFNAR blockade

Free
Laetitia Fend, Takahiro Yamazaki, Xavier Préville, Eric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan Pitt, Guido Kroemer, Laurence Zitvogel
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4563.
https://doi.org/10.1158/1538-7445.AM2017-4563
Published: 01 July 2017
View articletitled, Abstract 4563: Local and abscopal effects in oncolytic virotherapy are boosted by immune checkpoint blockade, immunogenic chemotherapy, or IFNAR blockade
Journal Articles

Abstract CT108: A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426)

Free
Jean-Francois Baurain, Ahmad Awada, Paal F. Brunsvig, Rebecca Kristeleit, Delphine Loirat, Dag Eirik Jøssang, Laurence Zitvogel, Guido Kroemer, Aurilièn Marabelle, Øystein Rekdal, Baldur Sveinbjørnsson, Hedda Wold, Berit Nicolaisen, Andrew Saunders, James Spicer
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT108.
https://doi.org/10.1158/1538-7445.AM2017-CT108
Published: 01 July 2017
View articletitled, Abstract CT108: A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426)
Journal Articles

Abstract 5128: Induction of immunogenic cell death and tumor regression in murine animal models by a novel cytolytic compound, LTX-401

Free
Brynjar Mauseth, Liv-Marie Eike, Ji-Hua Shi, Ketil Camilio, Heng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, Sylvèr Durand, Sabrina Forveille, Kristina Iribarren, Takahiro Yamazaki, Sylvie Souquere, Lucillia Bezu, Kevin Müller, Marion Leduc, Peng Liu, Liwei Zhao, Aurélien Marabelle, Laurence Zitvogel, Oliver Kepp, Guido Kroemer, Øystein Rekdal, Pål-Dag Line, Baldur Sveinbjørnsson
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5128.
https://doi.org/10.1158/1538-7445.AM2017-5128
Published: 01 July 2017
View articletitled, Abstract 5128: Induction of immunogenic cell death and tumor regression in murine animal models by a novel cytolytic compound, LTX-401
Journal Articles

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome

Free
Jonathan M. Pitt, Marie Vétizou, Nadine Waldschmitt, Guido Kroemer, Mathias Chamaillard, Ivo Gomperts Boneca, Laurence Zitvogel
Journal: Cancer Research
Cancer Res (2016) 76 (16): 4602–4607.
https://doi.org/10.1158/0008-5472.CAN-16-0448
Published: 14 August 2016
View articletitled, Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome
Open the PDF for Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome in another window
Journal Articles

Abstract 2326: LTX-315, an oncolytic peptide, increases anticancer immunity mediated by CTLA4 blockade in an interleukin-2 receptor beta-chain-dependent manner

Free
Takahiro Yamazaki, Marie Vetizou, Camila Flores, Aurelien Marabelle, Baldur Sveinbjørnsson, Øystein Rekdal, Guido Kroemer, Laurence Zitvogel
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2326.
https://doi.org/10.1158/1538-7445.AM2016-2326
Published: 15 July 2016
View articletitled, Abstract 2326: LTX-315, an oncolytic peptide, increases anticancer immunity mediated by CTLA4 blockade in an interleukin-2 receptor beta-chain-dependent manner
Journal Articles

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Free
Erika Vacchelli, David P. Enot, Federico Pietrocola, Laurence Zitvogel, Guido Kroemer
Journal: Cancer Research
Cancer Res (2016) 76 (11): 3122–3126.
https://doi.org/10.1158/0008-5472.CAN-16-0294
Published: 31 May 2016
View articletitled, Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy
Open the PDF for Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy in another window
Journal Articles

Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

Free
Jitka Fucikova, Etienne Becht, Kristina Iribarren, Jeremy Goc, Romain Remark, Diane Damotte, Marco Alifano, Priyanka Devi, Jerome Biton, Claire Germain, Audrey Lupo, Wolf Herve Fridman, Marie-Caroline Dieu-Nosjean, Guido Kroemer, Catherine Sautès-Fridman, Isabelle Cremer
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (7): 1746–1756.
https://doi.org/10.1158/0008-5472.CAN-15-1142
Published: 31 March 2016
View articletitled, Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
Open the PDF for Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis in another window
Journal Articles

STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Free
Heng Yang, Takahiro Yamazaki, Federico Pietrocola, Heng Zhou, Laurence Zitvogel, Yuting Ma, Guido Kroemer
Journal: Cancer Research
Cancer Res (2015) 75 (18): 3812–3822.
https://doi.org/10.1158/0008-5472.CAN-15-1122
Published: 14 September 2015
View articletitled, STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
Open the PDF for STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis

Free
Judith Michels, Aïcha Goubar, Julien Adam, Lorenzo Galluzzi, Ken André Olaussen, Angélique Robin, Philippe Girard, Isabelle Kremer, Maria Castedo, Jean-Charles Soria, Guido Kroemer
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4691.
https://doi.org/10.1158/1538-7445.AM2014-4691
Published: 01 October 2014
View articletitled, Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis
Journal Articles

CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy

Free
Yuting Ma, Stephen R. Mattarollo, Sandy Adjemian, Heng Yang, Laetitia Aymeric, Dalil Hannani, João Paulo Portela Catani, Helene Duret, Michele W.L. Teng, Oliver Kepp, Yidan Wang, Antonella Sistigu, Joachim L. Schultze, Gautier Stoll, Lorenzo Galluzzi, Laurence Zitvogel, Mark J. Smyth, Guido Kroemer
Journal: Cancer Research
Cancer Res (2014) 74 (2): 436–445.
https://doi.org/10.1158/0008-5472.CAN-13-1265
Published: 16 January 2014
View articletitled, CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
Open the PDF for CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy in another window
Includes: Supplementary data